Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004341:Drug Evaluation / Q000379:methods; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D007373:Interinstitutional Relations; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D010344:Patient Advocacy; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational